Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma, Astrazeneca, Daiichi, Gilead, Mannkind, Menarini, Minoryx, Neuraxpharm, Newamsterdam, Roche, Zevra.